Readings for Drugs and Behavior

Meyer, J.S. and Quenzer, L.F., 2018. Chapter 2: Psychopharmacology: drugs, the brain, and behavior. Oxford University Press

Knierim, J. Online Neuroscience Chapter 4: Basal Ganglia (Govern Medical School, UTHealth)

Frost, J. L., & Schafer, D. P. 2016. Microglia: architects of the developing nervous system. Trends in cell biology, 26(8), 587-597.

Nutt, D., 2006. GABA A receptors: subtypes, regional distribution, and function. Journal of Clinical Sleep Medicine, 2(02), pp.S7-S11.

Langston, J.W., 2017. The MPTP story. Journal of Parkinson's disease, 7(s1), pp.S11-S19.

Lewis, M., 2018. Brain change in addiction as learning, not disease. New England Journal of Medicine, 379(16), pp.1551-1560.

Bergman, H., et al., 1990. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science, 249(4975), pp.1436-1438.

Blinderman, CD. 2016 Psycho-existential distress in cancer patients: A return to “entheogens.” J Psychopharmacol. Dec;30(12):1205-1206.

Hart, C.L., 2020. Exaggerating harmful drug effects on the brain is killing black people. Neuron, 107(2), pp.215-218.

Thomas, K. 2016. Costly Drug for Fatal Muscular Disease Wins F.D.A. Approval. N.Y. Times.

Dittrich L. 2016. The Brain That Couldn’t Remember. N.Y. Times Magazine.

Muller, D. 2022. They Were Cigarette Smokers. Then a Stroke Vanquished Their Addiction. N.Y. Times

Moghaddam, B., 2021. Ketamine. MIT Press.

Girgis, R.R., Brucato, G. and Lieberman, J.A., 2020. Understanding and Caring for People with Schizophrenia: Fifteen Clinical Cases. Routledge.

Cahalan, S., 2013. Brain on fire: my month of madness. Simon and Schuster.

Silberman, S., 2015. Neurotribes: The legacy of autism and the future of neurodiversity. Penguin.